The FDA has approved Cabometyx for some patients 12 years old and older with previously treated neuroendocrine tumors. With the recent approval by the U.S. Food and Drug Administration (FDA) of ...

such as C 11-5HTP or Ga 68-DOTA octreotate, will improve staging and follow-up of therapy in patients with neuroendocrine tumors. Somatostatin analogs (e.g., octreotide, lanreotide) will continue ...

Getty A new study has found that the radiation from CT scans could eventually lead to over 100,000 future cancer diagnoses. On Monday, April 14, JAMA Internal Medicine — a monthly peer-reviewed ...

Popular CT Scans Could Account for 5% of All Cancer Cases a Year, Study Suggests Apr. 14, 2025 — CT scans may account for 5% of all cancers annually, according to a new study that cautions ...

The approval for use in advanced neuroendocrine tumors is supported by data from the phase 3 CABINET trial (ClinicalTrials.gov Identifier: NCT03375320). The double-blind, placebo-controlled study ...

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World Health Organization standards, the abnormal activation of oncogene FOXR2 ...

Understanding these interactions is important for the development of new therapies for cancer treatment. We identify an age-related subpopulation of RETNLγ + LCN2 + senescence-like neutrophils ...

A new study shows that CT scans are likely an "important cause of cancer" in the United States, resulting in over 100,000 cases annually. The new research was published in JAMA Internal Medicine on ...

The potential for miscommunication is high today. Not coming off the way you intended? Don’t try to force the point. Expressing yourself publicly can be a mixed bag while Mercury meets Neptune.

are helpful to assess the extent of the primary tumor and the potential spread of the cancer along nerves or to neck lymph nodes. Chest radiographs, CT scan and positron emission tomography (PET)/CT ...